Skip to main content

Table 7 The multivariate logistic regression model of low GPs` self-confidence in prescribing SGLT2ins

From: Barriers in prescribing antidiabetic medications with cardiovascular benefits: practice, experience, and attitudes of GPs in Croatia

 

β

Wald

P

OR

95% confidence interval

A greater number of individuals with T2D with already prescribed SGLT2ins

− 0.04

6.57

0.01

0.96

0.92 to 0.98

Barriers – knowledge

It is difficult for me to apply the principle of achieving HbA1c target values ​​and determining increased CV risk to one patient

0.76

7.09

0.008

2.2

1.22 to 3.73

Barriers – guidelines:

 Familiarity with GLP-1 RAs` side effects

1.57

5.43

0.02

4.8

1.28 to 17.9

 Familiarity with SGLT2ins` side effects

− 3.41

18.5

< 0.001

0.03

0.01 to 0.16

 The new guidelines` protocol that uses a double criterion for assessing the quality of T2D control helps in some cases, in some, it doesn't) vs. (yes, it sure helps)

1.69

7.4

0.006

5.4

1.61 to 18.05

 Constant

3.86

7.2

0.007

  
  1. β Regression coefficient, OR Odds ratio, T2D Type 2 diabetes, GLP-1 RAs Glucagon-like peptide-1 receptor agonists, SGLT2ins Sodium-glucose co-transporter 2 inhibitors, HbA1c Glycated hemoglobin, CV Cardiovascular